Alkermes
Alkermes is a provider of innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies its scientific expertise, proprietary technologies, and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.
Financial Data
-
31st Dec 17 Source: Company
- €742 million turnover
-
-€121 million
profit - 2,000 employees
-
31st Dec 16 Source: CRO
- €438 million turnover
-
€147.3 million
profit - 380 employees
- 5 more years available »
Ranking
By Turnover
(€742 million)- 107th in Top Companies
- 15th in Health
- 14th in Pharma
By Employees
(2,000)- 116th in Top Companies
- 19th in Health
- 9th in Pharma
-
- 2,000
- €742 million
Employees
- Richard Pops CEO/Managing Director
Latest News
- 7:34pm Pay dispute threatens to disrupt North’s electricity supply
- 6:37pm Shares slide as Brexit and US data stoke fears of a slow down
- 6:37pm Values slide as Brexit and US data stoke fears of slowdown
- 5:53pm Red Cow Moran Hotel sees book value more than double to €48.5m
- 5:00pm Netflix reinvents itself: ‘We’re really mostly a content company’